tirzepatide news november 2025 In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Arti Thangudu MD|Endocrinologist (Diabetes/Thyroid/Weight Loss)

Many patients remain asymptomatic until advanced disease develops, making incidental diagnosis through imaging or elevated liver enzymes common during routine health assessments

Any combination of biological, social, cultural, and environmental factors can cause eating disorders not just by exposure to diet culture

E., Hamad, N

Major medical organizations including the American Medical Association and American Heart Association recognize obesity as a chronic disease requiring pharmacologic treatment, yet many BCBS plans have not updated their policies accordingly

Bachem Holding AG These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition